New Business Tax System (Consolidation and Other Measures) Act 2003 (16 of 2003)
Schedule 9 Consolidation: foreign dividend accounts
Part 1 Basic amendments
Income Tax Assessment Act 1997
2 At the end of Division 719
Add:
Subdivision 719-X - International tax rules
Table of sections
Foreign dividend accounts
719-900 General rules about foreign dividend accounts
719-905 Transfer of balance of foreign dividend accounts on change in identity of provisional head company
Foreign dividend accounts
719-900 General rules about foreign dividend accounts
(1) This section modifies the effect that Subdivision 717-J has in relation to a *MEC group because of section 719-2.
Note: Except as provided by this section, section 719-2 gives Subdivision 717-J effect in relation to a MEC group in a way corresponding to the way in which that Subdivision has effect in relation to a consolidated group.
(2) Subdivision 717-J has effect in relation to the *provisional head company of the *MEC group in a way corresponding to the way in which that Subdivision has effect in relation to the *head company of a *consolidated group.
(3) Subdivision 717-J has effect as if:
(a) the company that is the *provisional head company of the *MEC group at a time were not a *subsidiary member of the group at the time; and
(b) each company that is a *member of the MEC group at the time and is not the provisional head company at the time were a subsidiary member of the group at the time.
719-905 Transfer of balance of foreign dividend accounts on change in identity of provisional head company
(1) This section operates if:
(a) a *cessation event happens to the *provisional head company (the old company ) of a *MEC group; and
(b) another company (the new company ) is appointed as the provisional head company of the group under subsection 719-60(3).
Note: The appointment of the new company as the provisional head company of a MEC group under subsection 719-60(3) is taken to have come into force immediately after the cessation event.
(2) If there was an *FDA surplus for the old company at the time of the *cessation event:
(a) an *FDA debit equal to the FDA surplus arises for the old company at the time of the cessation event; and
(b) an *FDA credit equal to the FDA surplus arises for the new company when it is appointed.
(3) If the old company's total *FDA debits arising before the time of the *cessation event exceeded its total *FDA credits arising before that time:
(a) an FDA credit equal to the excess arises for the old company at the time of the cessation event; and
(b) an FDA debit equal to the excess arises for the new company when it is appointed.
[The next Division is Division 721.]